Endoscopic Vessel Harvesting System Market Size & Forecasts 2026-2035, By Segments (Product, Application), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Getinge, LivaNova, Terumo, Maquet, Saphena Medical)

Market Outlook

Endoscopic Vessel Harvesting System Market size is set to grow from USD 162.22 million in 2025 to USD 231.05 million by 2035, reflecting a CAGR greater than 3.6% through 2026-2035. Industry revenues in 2026 are estimated at USD 167.18 million.

• Base Year Value (2025): USD 162.22 Million
• CAGR (2026-2035): 3.6%
• Forecast Year Value (2035): USD 231.05 Million
• Historical Data Period: 2021-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Key Takeaways

• North America region garnered more than 46.4% market share in 2025, due to advanced surgical infrastructure.
• Asia Pacific region will record around 4% CAGR through 2035, owing to rising minimally invasive surgeries.
• Achieving 54.5% endoscopic vessel harvesting system market share in 2025, the growth of disposable segment was underpinned by demand for minimally invasive procedures drives disposable EVH systems.
• The coronary artery disease (CAD) segment accounted for 63.7% of the endoscopic vessel harvesting system market in 2025, driven by high prevalence of CAD boosts procedure demand.
• Key companies dominating the endoscopic vessel harvesting system market are Getinge (Sweden), LivaNova (UK), Terumo (Japan), Maquet (Germany), Saphena Medical (USA), Cardio Medical (Germany), Med Europe (Italy), Sorin Group (Italy), Applied Medical (USA), Karl Storz (Germany).

Market Dynamics

Adoption of Endoscopic Vessel Harvesting Systems for Minimally Invasive Surgery

The increasing preference for minimally invasive surgical techniques is significantly influencing the endoscopic vessel harvesting system market. As healthcare providers seek to enhance patient outcomes and reduce recovery times, endoscopic vessel harvesting systems are becoming integral to surgical procedures. A report by the American College of Surgeons highlights that minimally invasive approaches lead to lower complication rates and shorter hospital stays, driving hospitals to adopt these technologies. This shift not only caters to patient demand for less invasive options but also aligns with broader healthcare trends towards efficiency and cost reduction. Consequently, established players can leverage this growing acceptance to expand their product lines, while new entrants can innovate around patient-centric solutions.

Expansion of Surgical Training and Hospital Procurement Programs

The expansion of surgical training initiatives and hospital procurement programs is reshaping the landscape of the endoscopic vessel harvesting system market. Institutions like the National Health Service (NHS) are increasingly investing in training programs to equip surgeons with the skills necessary for advanced techniques. This investment not only enhances surgical proficiency but also encourages the adoption of innovative technologies within hospitals. As procurement programs prioritize the acquisition of state-of-the-art systems, manufacturers are presented with strategic opportunities to collaborate with healthcare institutions, ensuring their products meet the evolving demands of surgical teams. This alignment between training and procurement is crucial for fostering a culture of innovation and excellence in surgical practices.

Development of AI-Assisted and Robotic Vessel Harvesting Systems

The emergence of AI-assisted and robotic vessel harvesting systems represents a transformative force within the endoscopic vessel harvesting system market. Companies like Intuitive Surgical are pioneering advancements that integrate artificial intelligence to enhance precision and reduce variability in surgical outcomes. These technological innovations not only improve operational efficiency but also respond to the increasing demand for high-quality care in surgical settings. As healthcare providers strive to adopt cutting-edge solutions, both established companies and startups have the opportunity to differentiate themselves through advanced offerings. The ongoing development in this space suggests a future where AI and robotics will play a central role in surgical procedures, fundamentally altering the operational dynamics of healthcare delivery.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Adoption of endoscopic vessel harvesting systems for minimally invasive surgery	1.50%	Short term (≤ 2 yrs)	North America, Europe (spillover: Asia Pacific)	Medium	Fast
Expansion of surgical training and hospital procurement programs	1.10%	Medium term (2–5 yrs)	Asia Pacific, North America (spillover: Europe)	Low	Moderate
Development of AI-assisted and robotic vessel harvesting systems	1.00%	Long term (5+ yrs)	Europe, Asia Pacific (spillover: North America)	Low	Slow

Industry Restraints:

Regulatory Compliance Challenges

The endoscopic vessel harvesting system market is significantly constrained by stringent regulatory compliance requirements imposed by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations necessitate extensive clinical trials and rigorous documentation, leading to prolonged product development cycles that can discourage innovation and delay market entry for new technologies. For instance, a recent report from the FDA highlighted that the average time for device approval has increased, creating operational inefficiencies that particularly affect smaller firms lacking the resources to navigate complex regulatory landscapes. As a result, established companies may consolidate their market positions, while new entrants face daunting barriers to entry, ultimately stifling competition and limiting advancements in surgical techniques.

Supply Chain Disruptions

Supply chain vulnerabilities further impede the growth of the endoscopic vessel harvesting system market, particularly in light of recent global events that have exposed the fragility of medical supply chains. The COVID-19 pandemic, as reported by the World Health Organization (WHO), has led to significant delays in the production and distribution of essential surgical instruments, which has resulted in postponed surgeries and reduced patient access to advanced treatment options. Such disruptions not only impact the operational capabilities of healthcare providers but also contribute to a hesitancy among consumers and healthcare administrators to adopt new technologies. For market participants, this translates into increased costs and potential reputational damage as they struggle to maintain consistent supply levels. In the near to medium term, these supply chain challenges are likely to persist, compelling companies to invest in more resilient logistics and sourcing strategies to mitigate risks and ensure continuity in service delivery.

Regional Forecast

North America Market Statistics:

North America captured over 46.4% of the global endoscopic vessel harvesting system market in 2025, establishing itself as the largest region in this sector. This dominance is attributed to advanced surgical infrastructure, which facilitates the adoption of innovative medical technologies. The region's healthcare systems are characterized by high investment in surgical advancements and a strong emphasis on minimally invasive procedures, aligning with evolving consumer preferences for less invasive treatment options. Furthermore, the ongoing digital transformation in healthcare, along with robust regulatory frameworks that support innovation, enhances the region's competitive edge. Institutions like the American College of Surgeons have noted significant improvements in patient outcomes due to these advancements, indicating a favorable environment for growth. Looking ahead, North America presents substantial opportunities for stakeholders in the endoscopic vessel harvesting system market due to its commitment to technological integration and improved patient care pathways.

The United States anchors the North American market for endoscopic vessel harvesting systems, driven by its sophisticated healthcare infrastructure and a culture of innovation. The U.S. healthcare landscape is marked by a strong focus on technological advancements, with significant investments from both public and private sectors aimed at enhancing surgical capabilities. For instance, the U.S. Food and Drug Administration (FDA) has been proactive in streamlining the approval processes for new surgical technologies, which fosters a competitive environment ripe for innovation. Additionally, the rising prevalence of cardiovascular diseases has led to increased demand for effective surgical solutions, further propelling the market. This unique confluence of factors positions the U.S. as a vital player in the regional endoscopic vessel harvesting system market, ultimately contributing to North America's leadership.

Canada also plays a pivotal role in the North American endoscopic vessel harvesting system market, characterized by a strong emphasis on healthcare accessibility and quality. The Canadian healthcare system's commitment to evidence-based practices has led to the adoption of advanced surgical technologies that improve patient outcomes. Health Canada has actively supported initiatives that promote the use of minimally invasive surgical techniques, thus aligning with patient preferences for safer and less traumatic procedures. Furthermore, the collaboration between healthcare providers and technology firms fosters a dynamic environment for innovation. As Canada continues to enhance its surgical capabilities, it reinforces North America's position as a leader in the endoscopic vessel harvesting system market, creating synergies that benefit the entire region.

Asia Pacific Market Analysis:

Asia Pacific emerged as the fastest-growing region in the endoscopic vessel harvesting system market, registering a robust CAGR of 4%. This growth is primarily driven by the rising demand for minimally invasive surgeries, which are increasingly preferred for their reduced recovery times and lower complication rates. The region's healthcare landscape is evolving, with a notable shift towards advanced surgical techniques that enhance patient outcomes. As healthcare providers prioritize efficiency and patient-centric care, the adoption of endoscopic vessel harvesting systems is gaining traction, supported by technological advancements and an increasing focus on surgical precision.

Japan plays a pivotal role in the Asia Pacific endoscopic vessel harvesting system market, characterized by its commitment to healthcare innovation and high standards in surgical practices. The rising trend of minimally invasive surgeries is particularly pronounced in Japan, where patients and healthcare professionals alike are prioritizing procedures that minimize trauma and expedite recovery. The Japanese government’s support for advanced medical technologies, alongside a well-established healthcare infrastructure, fosters an environment conducive to the adoption of these systems. For instance, the Ministry of Health, Labour and Welfare has been actively promoting initiatives that encourage the integration of cutting-edge surgical technologies into clinical practice. This strategic focus not only enhances patient care but also positions Japan as a leader in the regional market, creating significant opportunities for growth in the endoscopic vessel harvesting system sector.

China is also a critical player in the Asia Pacific endoscopic vessel harvesting system market, driven by its rapidly expanding healthcare sector and increasing investments in medical technology. The demand for minimally invasive surgeries is surging, influenced by a growing middle class that seeks higher-quality healthcare options. Chinese hospitals are increasingly adopting advanced surgical techniques to meet this demand, supported by government policies aimed at improving healthcare accessibility and quality. Recent reports from the National Health Commission highlight substantial investments in surgical innovations and training programs for healthcare professionals, which are essential for the successful implementation of endoscopic vessel harvesting systems. This environment not only enhances the competitive landscape but also aligns with the broader regional trend towards modernization in surgical practices, thereby reinforcing China's strategic importance in the Asia Pacific market.

Europe Market Trends:

The endoscopic vessel harvesting system market in Europe held a commanding share, driven by a robust healthcare infrastructure and increasing adoption of minimally invasive surgical techniques. This region's significance is underscored by its advanced technological landscape, which fosters innovation and enhances patient outcomes. The growing emphasis on patient-centric care and surgical efficiency has led to a shift in demand towards these systems. Moreover, regulatory frameworks across European countries are evolving to support the integration of advanced medical technologies, bolstered by a strong focus on sustainability in healthcare practices. For instance, the European Union's Medical Device Regulation (MDR) has prompted manufacturers to enhance their product offerings, ensuring compliance while meeting the market's sustainability priorities. These dynamics, coupled with a skilled workforce and increasing investment in healthcare R&D, position Europe as a fertile ground for growth in the endoscopic vessel harvesting system market.

Germany plays a pivotal role in the endoscopic vessel harvesting system market, characterized by its strong emphasis on innovation and quality in healthcare delivery. The country has seen a significant uptick in the adoption of these systems, driven by a well-established regulatory environment and a growing demand for minimally invasive procedures among patients. The Federal Ministry of Health has been instrumental in promoting advanced surgical techniques, which has led to increased funding for hospitals to acquire state-of-the-art equipment. For example, recent initiatives by the German Hospital Federation highlight the need for modernization in surgical practices, thereby enhancing the competitive landscape for endoscopic vessel harvesting systems. This growth trajectory not only reinforces Germany's leadership in the region but also presents substantial opportunities for manufacturers seeking to expand their market presence.

France also contributes significantly to the endoscopic vessel harvesting system market, marked by a strong cultural inclination towards innovative healthcare solutions. The French healthcare system is increasingly prioritizing minimally invasive techniques, reflecting a shift in consumer preferences towards procedures that promise quicker recovery times and reduced complications. The French National Authority for Health (HAS) has been proactive in endorsing new technologies that improve surgical outcomes, which has catalyzed the adoption of endoscopic vessel harvesting systems in hospitals across the country. Notably, the collaboration between public health institutions and private sector innovators has led to advancements in surgical technology, positioning France as a key player in the European market. As such, this favorable regulatory and cultural environment not only enhances France's market share but also aligns with broader regional opportunities for growth in the endoscopic vessel harvesting system market.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Nascent
Cost-Sensitive Region	Medium	High	Medium	High	High
Regulatory Environment	Supportive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Moderate	Strong	Moderate	Weak
Development Stage	Developed	Developing	Developed	Developing	Emerging
Adoption Rate	High	Medium	High	Medium	Low
New Entrants / Startups	Moderate	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Weak	Weak

Segmentation Analysis

 

Analysis by Disposable

The endoscopic vessel harvesting system market for disposable products dominated the segment with a commanding 54.5% share in 2025. This leadership can be attributed to the increasing demand for minimally invasive procedures, which significantly enhances patient recovery times and reduces hospital stays. As healthcare providers prioritize patient-centric approaches, the preference for disposable EVH systems grows, aligning with sustainability priorities and the need for efficient supply chain management. According to the World Health Organization, the shift towards minimally invasive techniques is reshaping surgical practices globally, further solidifying the position of disposable systems. This segment offers strategic advantages for both established firms and emerging players, as they can leverage technological innovations to meet evolving customer expectations. Moving forward, the disposable segment is expected to remain relevant due to ongoing advancements in surgical technologies and the rising emphasis on patient safety and comfort.

Analysis by Coronary Artery Disease (CAD)

The endoscopic vessel harvesting system market for coronary artery disease (CAD) applications captured over 63.7% share of the segment in 2025. This significant share is driven by the high prevalence of CAD, which continues to propel the demand for effective surgical interventions. As healthcare systems focus on improving cardiovascular health, the integration of advanced endoscopic techniques is becoming increasingly critical. The American Heart Association highlights that the growing incidence of CAD necessitates innovative solutions, leading to a robust market for CAD-focused EVH systems. The opportunities in this segment are substantial, as both established firms and new entrants can develop tailored solutions that address specific patient needs. In the near to medium term, the CAD segment is expected to maintain its relevance due to continuous advancements in diagnostic and therapeutic technologies aimed at enhancing patient outcomes.

Report Segmentation
Segment	Sub-Segment
Product	Disposable, Re-usable
Application	Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD)

Competitive Landscape

Key players in the endoscopic vessel harvesting system market include Getinge, LivaNova, Terumo, Maquet, Saphena Medical, Cardio Medical, Med Europe, Sorin Group, Applied Medical, and Karl Storz. These companies are recognized for their innovative technologies and robust product portfolios, positioning them as leaders in this specialized field. Getinge and LivaNova, for instance, have established strong reputations through their commitment to advancing surgical techniques and improving patient outcomes. Similarly, Terumo and Maquet leverage their extensive experience in medical devices to enhance the efficiency and effectiveness of endoscopic procedures, while Saphena Medical and Cardio Medical focus on niche applications, contributing significantly to market dynamics. The prominence of these players is further underscored by their strategic investments in research and development, which continue to push the boundaries of vessel harvesting technology.

The competitive landscape of the endoscopic vessel harvesting system market is characterized by dynamic interactions among the top players, who actively pursue various initiatives to enhance their market standing. Notably, collaborations between companies like Saphena Medical and established medical institutions have fostered innovation and streamlined product development. Furthermore, the launch of advanced endoscopic systems by Karl Storz and Applied Medical reflects a commitment to addressing emerging surgical needs, thereby reshaping competitive dynamics. The strategic alignment of these players through partnerships and technology investments has not only bolstered their innovation capabilities but also reinforced their competitive edge in a rapidly evolving market.

Strategic / Actionable Recommendations for Regional Players

In North America, fostering partnerships with leading healthcare institutions can enhance product visibility and adoption. Emphasizing the integration of cutting-edge technologies such as artificial intelligence in surgical procedures may lead to enhanced operational efficiencies and superior patient outcomes. Additionally, targeting specific segments such as minimally invasive cardiac surgery could yield significant growth opportunities.

For players in the Asia Pacific region, exploring collaborations with local medical device manufacturers can facilitate market entry and expansion. Embracing emerging technologies, particularly in telemedicine, may provide avenues for innovative solutions that cater to the unique needs of this diverse market. Moreover, focusing on training and education initiatives for healthcare professionals can drive the adoption of advanced endoscopic techniques.

In Europe, building alliances with regulatory bodies and healthcare organizations can streamline the approval process for new products, enhancing market responsiveness. Leveraging insights from ongoing clinical studies may inform product development and positioning strategies. Additionally, investing in sustainable practices and eco-friendly technologies could resonate with the growing emphasis on healthcare sustainability, appealing to both providers and patients.